
Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
5/5/2025
0:00
21:13
Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.
Related Content:
More episodes from "JAMA Neurology Author Interviews"



Don't miss an episode of “JAMA Neurology Author Interviews” and subscribe to it in the GetPodcast app.







